FDA CDC News2 years ago
FDA Approves First Gene Therapy to Treat Adults with Hemophilia B
U.S. FDA approved Hemgenix, an adeno-associated virus vector-based gene therapy for the treatment of adults with Hemophilia B who currently use Factor IX prophylaxis therapy, or...
